State CO
Clinical Trials in Colorado
Recruiting clinical trials with at least one study location in Colorado. Data updated daily from ClinicalTrials.gov.
Top Conditions in Colorado
NCT06103136 N/A
Recruiting
Maestro 1.1 Post-Market Registry
Condition
Surgery
Enrollment
600 pts
Location
United States, Belgium, France
Sponsor
Moon Surgical
NCT07174583 Phase 1, Phase 2
Recruiting
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell L...
Condition
Small-cell Lung Cancer
Enrollment
208 pts
Location
United States, Australia, Brazil
Sponsor
IDEAYA Biosciences
NCT05410145 Phase 1, Phase 2
Recruiting
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced ...
Condition
KRAS P.G12C
Enrollment
442 pts
Location
United States, Australia, China
Sponsor
D3 Bio (Wuxi) Co., Ltd
NCT06683092 N/A
Recruiting
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Condition
Cystic Fibrosis
Enrollment
200 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT06769022 N/A
Recruiting
Exercise Adherence and Cognitive Decline
Condition
Cognitive Decline
Enrollment
20 pts
Location
United States
Sponsor
University of Colorado, Boulde
NCT07280065 Phase 3
Recruiting
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
Condition
PTSD - Post Traumatic Stress Disorder
Enrollment
1,900 pts
Location
United States, Australia
Sponsor
Senseye, Inc.
NCT06131801 N/A
Recruiting
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solutio...
Condition
Hematologic Malignancy
Enrollment
30 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT05230173 N/A
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remi...
Condition
Ulcerative Colitis
Enrollment
250 pts
Location
United States
Sponsor
University of California, San
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT07206056 Phase 1, Phase 2
Recruiting
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tul...
Condition
Progressive Metastatic Castrate Resistant Prostate Cancer
Enrollment
188 pts
Location
United States, Australia, China
Sponsor
Novartis Pharmaceuticals
NCT05156983 Phase 3
Recruiting
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Nee...
Condition
Coagulation Disorder
Enrollment
328 pts
Location
United States, Argentina, Austria
Sponsor
Takeda
NCT06272045 N/A
Recruiting
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Condition
Cardiovascular Health
Enrollment
6,618 pts
Location
United States
Sponsor
JHSPH Center for Clinical Tria
NCT05065372 Phase 1
Recruiting
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Va...
Condition
Type 1 Diabetes
Enrollment
60 pts
Location
United States
Sponsor
Kalie Tommerdahl
NCT05458674 Phase 2
Recruiting
Tucatinib+Trastuzumab+Eribulin in HER2+ MBC
Condition
Breast Cancer
Enrollment
30 pts
Location
United States
Sponsor
Criterium, Inc.
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT07209072 N/A
Recruiting
Emergency Department Linkage to Care for Patients Experiencing Homelessness
Condition
Homelessness
Enrollment
390 pts
Location
United States
Sponsor
Denver Health and Hospital Aut
NCT04513782 N/A
Recruiting
The Contributions of Age Related Changes in the Sound Localization Pathway to Ce...
Condition
Healthy Individuals
Enrollment
200 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT07005362 N/A
Recruiting
Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D
Condition
Type 2 Diabetes
Enrollment
36 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT06422923 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral...
Condition
Epilepsy, Temporal Lobe
Enrollment
10 pts
Location
United States
Sponsor
Neurona Therapeutics
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06161974 Phase 2
Recruiting
Study of Olutasidenib and Temozolomide in HGG
Condition
High Grade Glioma
Enrollment
60 pts
Location
United States, Australia, Canada
Sponsor
Rigel Pharmaceuticals
NCT05213676 Phase 4
Recruiting
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
Condition
Congenital Diaphragmatic Hernia
Enrollment
600 pts
Location
United States
Sponsor
The University of Texas Health
NCT05104983 Phase 2
Recruiting
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Condition
Tuberous Sclerosis Complex
Enrollment
64 pts
Location
United States
Sponsor
Darcy Krueger
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT06719141 Phase 3
Recruiting
A Study to Investigate LP352 in Children and Adults With Developmental and Epile...
Condition
Developmental and Epileptic Encephalopathy
Enrollment
320 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals